Dobutamine stress echocardiography and troponin T as a marker of myocardial injury

被引:7
作者
Pastor, G [1 ]
San Román, JA [1 ]
González-Sagrado, M [1 ]
Vega, JL [1 ]
Arranz, ML [1 ]
Serrador, AM [1 ]
Epureanu, V [1 ]
Palomino, RT [1 ]
Sanz, O [1 ]
Tejedor, P [1 ]
Fernández-Avilés, F [1 ]
机构
[1] Hosp Rio Hortega, Serv Anal Clin, Valladolid, Spain
来源
REVISTA ESPANOLA DE CARDIOLOGIA | 2002年 / 55卷 / 05期
关键词
dobutamine; stress echocardiography; troponin; coronary disease;
D O I
10.1016/S0300-8932(02)76637-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction and objectives. Troponin T (TnT) is a very specific marker of myocardial damage. Our objective was to describe TnT behavior after dobutamine stress echocardiography (EDOB) and evaluate its usefulness for improving the diagnostic power of EDOB. Methods. Blood levels of TnT were measured at baseline and 3, 6, 12, and 24 h after EDOB in 63 patients (mean age: 69 +/- 9; 38 males). Coronary angiography was performed on 36 patients. Results. EDOB was positive in 29 patients and there was an increase over baseline values in 15 of them (51%); EDOB was negative in 34 patients and there was only a rise in TnT in 7 (20%; p < 0.01). The TnT increment was higher in patients with a positive response to EDOB (0.033 +/- 0.02 vs. 0.026 +/- 0.01; p < 0.01). The ischemia score index was higher in patients in which a significant increase in TnT values was later detected (0.41 +/- 0.31 vs. 0.38 +/- 0.20; p < 0.01). Coronariography was performed in 36 patients. EDOB was positive in 22 of the 29 patients with coronary artery disease (76%) and TnT was raised in 14 of them (48%; p < 0.05). Conclusion. The rise in TnT levels during EDOB suggests that this test may produce myocardial damage associated with the appearance of contractility disorders during dobutamine infusion.
引用
收藏
页码:469 / 473
页数:5
相关论文
共 21 条
[1]   Myocardial infarction redefined -: A consensus Document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction [J].
Alpert, JS ;
Antman, E ;
Apple, F ;
Armstrong, PW ;
Bassand, JP ;
de Luna, AB ;
Beller, G ;
Breithardt, G ;
Chaitman, BR ;
Clemmensen, P ;
Falk, E ;
Fishbein, MC ;
Galvani, M ;
Garson, A ;
Grines, C ;
Hamm, C ;
Jaffe, A ;
Katus, H ;
Kjekshus, J ;
Klein, W ;
Klootwijk, P ;
Lenfant, C ;
Levy, D ;
Levy, RI ;
Luepker, R ;
Marcus, F ;
Näslund, U ;
Ohman, M ;
Pahlm, O ;
Poole-Wilson, P ;
Popp, R ;
Alto, P ;
Pyörälä, K ;
Ravkilde, J ;
Rehnquist, N ;
Roberts, W ;
Roberts, R ;
Roelandt, J ;
Rydén, L ;
Sans, S ;
Simoons, ML ;
Thygesen, K ;
Tunstall-Pedoe, H ;
Underwood, R ;
Uretsky, BF ;
Van de Werf, F ;
Voipio-Pulkki, LM ;
Wagner, G ;
Wallentin, L ;
Wijns, W .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (03) :959-969
[2]   Tissue specificity of cardiac troponin I, cardiac troponin T and creatine kinase-MB [J].
Apple, FS .
CLINICA CHIMICA ACTA, 1999, 284 (02) :151-159
[3]   Does dobutamine stress echocardiography induce damage during viability diagnosis of patients with chronic regional dysfunction after myocardial infarction? [J].
Beckmann, S ;
Bocksch, W ;
Muller, C ;
Schartl, M .
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 1998, 11 (02) :181-187
[4]  
de la Torre MD, 1999, REV ESP CARDIOL, V52, P237
[5]  
de Rozas JM, 2001, REV ESP CARDIOL, V54, P1345
[6]  
Filatov VL, 1999, BIOCHEMISTRY-MOSCOW+, V64, P969
[7]   Cardiac markers: point of care testing [J].
Hudson, MP ;
Christenson, RH ;
Newby, LK ;
Kaplan, AL ;
Ohman, EM .
CLINICA CHIMICA ACTA, 1999, 284 (02) :223-237
[8]  
LINDAHL B, 1998, EUR HEART J SUPPL, V19, P51
[9]   Can dobutamine echocardiography induce myocardial damage in patients with dysfunctional but viable myocardium supplied by a severely stenotic coronary artery? [J].
Meluzin, J ;
Toman, J ;
Groch, L ;
Hornacek, I ;
Sitar, J ;
Fischerova, B ;
Kara, T .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 1997, 61 (02) :175-181
[10]   Use of biochemical markers in acute coronary syndromes [J].
Panteghini, M ;
Apple, FS ;
Christenson, RH ;
Dati, F ;
Mair, J ;
Wu, AH .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 1999, 37 (06) :687-693